| RS111385795 |
HCFC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonic acidemia with homocystinuria, type cblX |
| RS111386656 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS111386779 |
CBS
|
Health Risk |
Conflicting classifications of pathogenicity |
Classic homocystinuria, HYPERHOMOCYSTEINEMIA |
| RS111387355 |
XPO5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS111387770 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS111391222 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, Ehlers-Danlos syndrome |
| RS111392103 |
APTX
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia, early-onset |
| RS111392631 |
LRPPRC
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS111392970 |
EEF1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 33 |
| RS111395856 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Dystonia 27 |
| RS111396594 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS111396698 |
POLN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS111397747 |
PFKM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type VII |
| RS111399879 |
B4GALT1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS111400183 |
NOD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Regional enteritis, Blau syndrome |
| RS111400659 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypercholesterolemia, Hypercholesterolemia |
| RS111401431 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Marfan syndrome, 8 conditions |
| RS111401822 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS111404182 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 4 |
| RS111405249 |
SLX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group P |
| RS111406690 |
TNNI3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS111407265 |
ASL
|
Health Risk |
Pathogenic/Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS111413134 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1114167274 |
FTL
|
Health Risk |
Pathogenic |
Neuroferritinopathy, Neuroferritinopathy |
| RS1114167276 |
SMARCAD1
|
Health Risk |
Pathogenic |
Adermatoglyphia, Keratoderma with scleroatrophy of the extremities |
| RS1114167277 |
SMARCAD1
|
Health Risk |
Pathogenic |
Adermatoglyphia, Adermatoglyphia |
| RS1114167280 |
ARHGAP29
|
Health Risk |
Pathogenic |
Nonsyndromic cleft lip with or without cleft palate, Nonsyndromic cleft lip with or without cleft palate |
| RS1114167281 |
ARHGAP29
|
Health Risk |
Pathogenic |
Nonsyndromic cleft lip with or without cleft palate, Nonsyndromic cleft lip with or without cleft palate |
| RS1114167282 |
ARHGAP29
|
Health Risk |
Pathogenic |
Nonsyndromic cleft lip with or without cleft palate, Nonsyndromic cleft lip with or without cleft palate |
| RS1114167283 |
PORCN
|
Health Risk |
Pathogenic |
Focal dermal hypoplasia, Inborn genetic diseases |
| RS1114167284 |
ACO2
|
Health Risk |
Likely pathogenic |
Infantile cerebellar-retinal degeneration, Infantile cerebellar-retinal degeneration |
| RS1114167285 |
SARS2
|
Health Risk |
Pathogenic |
Hyperuricemia, pulmonary hypertension |
| RS1114167286 |
MLC1
|
Health Risk |
Pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS1114167287 |
HEXB
|
Health Risk |
Pathogenic/Likely pathogenic |
Sandhoff disease, Sandhoff disease |
| RS1114167288 |
HIBCH
|
Health Risk |
Conflicting classifications of pathogenicity |
3-hydroxyisobutyryl-CoA hydrolase deficiency, 3-hydroxyisobutyryl-CoA hydrolase deficiency |
| RS1114167289 |
PHF6
|
Health Risk |
Pathogenic |
Borjeson-Forssman-Lehmann syndrome, Borjeson-Forssman-Lehmann syndrome |
| RS1114167290 |
MYO5A
|
Health Risk |
Pathogenic |
Cerebellar cortical atrophy, Dystonic disorder |
| RS1114167291 |
ANKRD11
|
Health Risk |
Pathogenic |
10 conditions, 10 conditions |
| RS1114167293 |
C12orf57
|
Health Risk |
Pathogenic |
6 conditions, Temtamy syndrome |
| RS1114167295 |
MAGED2
|
Health Risk |
Likely pathogenic |
6 conditions, 6 conditions |
| RS1114167296 |
TMEM47
|
Health Risk |
Likely pathogenic |
6 conditions, 6 conditions |
| RS1114167297 |
KIF5B
|
Health Risk |
Likely pathogenic |
Attention deficit hyperactivity disorder, Global developmental delay |
| RS1114167298 |
GRM7
|
Health Risk |
Pathogenic |
Brain atrophy, Global developmental delay |
| RS1114167300 |
GRM7
|
Health Risk |
Pathogenic/Likely pathogenic |
6 conditions, Neurodevelopmental disorder with seizures |
| RS1114167301 |
GRM7
|
Health Risk |
Pathogenic/Likely pathogenic |
6 conditions, Neurodevelopmental disorder with seizures |
| RS1114167302 |
MKS1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS1114167303 |
SON
|
Health Risk |
Pathogenic/Likely pathogenic |
Failure to thrive, Global developmental delay |
| RS1114167305 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS1114167306 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS1114167307 |
GJA3
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental cataract, Congenital cataracts-facial dysmorphism-neuropathy syndrome |
| RS1114167311 |
CRYAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental cataract, Cataract 9 multiple types |
| RS1114167312 |
CRYGS
|
Health Risk |
Pathogenic |
Developmental cataract, Developmental cataract |
| RS1114167313 |
GCNT2
|
Health Risk |
Pathogenic |
Developmental cataract, Developmental cataract |
| RS1114167314 |
GCNT2
|
Health Risk |
Likely pathogenic |
Developmental cataract, Developmental cataract |
| RS1114167315 |
MIP
|
Health Risk |
Pathogenic |
Developmental cataract, Developmental cataract |
| RS1114167316 |
ITPR1
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 29, Spinocerebellar ataxia type 29 |
| RS1114167317 |
PLAG1
|
Health Risk |
Pathogenic |
Silver-Russell syndrome 1, Silver-russell syndrome 4 |
| RS1114167318 |
PLAG1
|
Health Risk |
Pathogenic |
Silver-Russell syndrome 1, Silver-russell syndrome 4 |
| RS1114167319 |
HMGA2
|
Health Risk |
Pathogenic |
Silver-Russell syndrome 1, Silver-Russell syndrome 5 |
| RS1114167320 |
HMGA2
|
Health Risk |
Pathogenic |
Silver-Russell syndrome 1, Silver-Russell syndrome 5 |
| RS1114167321 |
IGF2
|
Health Risk |
Pathogenic |
Silver-Russell syndrome 1, Silver-Russell syndrome 1 |
| RS1114167323 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1S, Dilated cardiomyopathy 1S |
| RS1114167324 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1S, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1114167331 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1S, Dilated cardiomyopathy 1DD |
| RS1114167332 |
DES
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1S, Dilated cardiomyopathy 1S |
| RS1114167333 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1S, Dilated cardiomyopathy 1S |
| RS1114167335 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1S, Dilated cardiomyopathy 1S |
| RS1114167338 |
TTN
|
Health Risk |
Likely pathogenic |
Left ventricular noncompaction 2, Left ventricular noncompaction 2 |
| RS1114167340 |
TNNI3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, familial restrictive |
| RS1114167341 |
CRYAB
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, familial restrictive |
| RS1114167342 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 9, Hypertrophic cardiomyopathy |
| RS1114167345 |
LMNA
|
Health Risk |
Likely pathogenic |
Arrhythmogenic right ventricular dysplasia 9, Arrhythmogenic right ventricular dysplasia 9 |
| RS1114167348 |
KMT2D
|
Health Risk |
Pathogenic |
Smith-Magenis Syndrome-like, Smith-Magenis Syndrome-like |
| RS1114167349 |
ZEB2
|
Health Risk |
Likely pathogenic |
Smith-Magenis Syndrome-like, Mowat-Wilson syndrome |
| RS1114167350 |
JAKMIP1
|
Health Risk |
Pathogenic |
Smith-Magenis Syndrome-like, Smith-Magenis Syndrome-like |
| RS1114167351 |
MAP2K2
|
Health Risk |
Pathogenic |
Smith-Magenis Syndrome-like, Smith-Magenis Syndrome-like |
| RS1114167352 |
CASK
|
Health Risk |
Pathogenic/Likely pathogenic |
Smith-Magenis Syndrome-like, CASK-related disorder |
| RS1114167353 |
GLDC
|
Health Risk |
Pathogenic |
Smith-Magenis Syndrome-like, Smith-Magenis Syndrome-like |
| RS1114167354 |
PARD3
|
Health Risk |
Pathogenic |
Neural tube defect, Neural tube defect |
| RS1114167355 |
TPM1
|
Health Risk |
Likely pathogenic |
Pulmonary atresia with intact ventricular septum, Pulmonary atresia with intact ventricular septum |
| RS1114167356 |
TPM1
|
Health Risk |
Likely pathogenic |
Atrial septal defect 1, Atrial septal defect 1 |
| RS1114167358 |
LIFR
|
Health Risk |
Pathogenic |
Congenital anomaly of kidney and urinary tract, Congenital anomaly of kidney and urinary tract |
| RS1114167359 |
COL18A1
|
Health Risk |
Likely pathogenic |
Knobloch syndrome, Thyroid cancer |
| RS1114167360 |
TRPM6
|
Health Risk |
Pathogenic |
Intestinal hypomagnesemia 1, Intestinal hypomagnesemia 1 |
| RS1114167361 |
FLNC
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 26, Myofibrillar myopathy 5 |
| RS1114167362 |
LMX1B
|
Health Risk |
Pathogenic |
Nail-patella syndrome, Nail-patella syndrome |
| RS1114167366 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1114167370 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS1114167371 |
COL4A3
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1114167374 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1114167375 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1114167377 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1114167378 |
COL1A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type I, 8 conditions |
| RS1114167379 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1114167380 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1114167381 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1114167382 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1114167384 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1114167385 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1114167387 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |